株式会社D&Mカンパニー Logo

株式会社D&Mカンパニー

Optimizing healthcare & welfare businesses via finance, consulting, and HR solutions.

189A | T

Overview

Corporate Details

ISIN(s):
JP3548490006
LEI:
Country:
Japan
Address:
大阪市北区梅田二丁目5番25号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D&M COMPANY CO.,LTD is a specialized provider of comprehensive business support services for the medical, nursing care, and welfare industries. The company offers integrated, one-stop solutions structured around three core pillars: Finance & Investment (F&I), Consulting & Business Renovation (C&Br), and Human Resources & Outsourcing (HR&OS). The F&I division provides financial solutions such as medical fee receivables factoring and leasing. The C&Br division offers management consulting, including organizational reform, profit improvement support, and M&A advisory. The HR&OS division delivers staffing services like personnel placement, temporary staffing, and outsourcing. By holistically addressing key client challenges in finance, management, and human resources, D&M aims to achieve overall business optimization for healthcare and welfare service providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 330.4 KB
2025-08-25 06:04
Registration Form
有価証券報告書-第10期(2024/06/01-2025/05/31)
Japanese 1.3 MB
2025-08-25 06:04
Registration Form
確認書
Japanese 9.2 KB
2025-01-14 05:43
Report Publication Announcement
確認書
Japanese 9.3 KB
2025-01-14 05:41
Interim Report
半期報告書-第10期(2024/06/01-2025/05/31)
Japanese 179.0 KB
2024-08-27 03:02
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-08-26 08:01
Registration Form
確認書
Japanese 8.8 KB
2024-08-26 08:00
Annual Report
有価証券報告書-第9期(2023/06/01-2024/05/31)
Japanese 1.3 MB
2024-06-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-24 02:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2024-05-08 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.0 MB

Automate Your Workflow. Get a real-time feed of all 株式会社D&Mカンパニー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社D&Mカンパニー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社D&Mカンパニー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom
CIZ
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America
CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America
CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America
SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan
7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA

Talk to a Data Expert

Have a question? We'll get back to you promptly.